First Command Financial Services »

Mink Therapeutics shares owned by First Command Financial Services

Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by First Command Financial Services from 13F filings

Historical chart of First Command Financial Services investment in Mink Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mink Therapeutics held by First Command Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mink Therapeutics by First Command Financial Services

Quarter filed Position value Share count Share price at filing
2023-06-30 $2.2k 1.0k 2.10

More positions owned by First Command Financial Services

iShares Core MSCI EAFE ETF Core Msci Eafe (IEFA)
iShares Core S&P 500 ETF Core S&p500 Etf (IVV)
Vanguard Mid-Cap ETF Mid Cap Etf (VO)
iShares Core Dividend Growth ETF Core Div Grwth (DGRO)
SPDR Portfolio S&P 500 High Dividend ETF Prtflo S&p500 Hi (SPYD)
SPDR Portfolio S&P 500 Growth ETF Prtflo S&p500 Gw (SPYG)
Invesco S&P 500 Quality ETF S&p500 Quality (SPHQ)
iShares Gold Trust ETF Ishares New (IAU)
iShares 0-5 Year TIPS Bond ETF 0-5 Yr Tips Etf (STIP)
Vanguard Real Estate ETF Real Estate Etf (VNQ)
Vanguard Small-Cap ETF Small Cp Etf (VB)
Goldman Sachs ActiveBeta US Large Cap Equity ETF Activebeta Us Lg (GSLC)
Vanguard 500 Index Fund ETF S&p 500 Etf Shs (VOO)
Dimensional International Value ETF Internatnal Val (DFIV)
Dimensional U S Small Cap ETF Us Small Cap Etf (DFAS)

View all positions for First Command Financial Services

Top funds holding Mink Therapeutics

Vanguard Group
Longbow Finance SA
Renaissance Technologies
Geode Capital Management
BlackRock
BlackRock
HighTower Advisors
State Street Corporation
Goldman Sachs Group
Captrust Financial Advisors
Northern Trust
Greenwich Wealth Management
Wells Fargo & Company
Tower Research Capital
Bank of America Corporation

View all funds holding Mink Therapeutics